Alzheimer’s disease (AD) and a subset of frontotemporal dementia termed FTLD-Tau are characterized by a massive, yet incompletely characterized and understood redistribution of Tau. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.